Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 586 of 5804
-
Radioactive beads take aim at untreatable liver tumors
Disease control OngoingThis is a prospective, multi-center, open-label study to evaluate the effectiveness and safety of Eye90 microspheres® in the treatment of subjects with unresectable Hepatocellular Carcinoma (HCC). Eye90 microspheres is a medical device containing yttrium-90 (Y-90), a radioactive …
Phase: NA • Sponsor: ABK Biomedical • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New hope for leiomyosarcoma: drug combo trial aims to slow tumor growth
Disease control OngoingThe primary objective of this phase III trial is to evaluate whether the combination of lurbinectedin plus doxorubicin given as first line treatment for metastatic leiomyosarcoma (LMS) prolongs the progression-free survival (PFS) by Independent Review Committee (IRC) when compare…
Phase: PHASE3 • Sponsor: PharmaMar • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Abdominal chemotherapy after surgery may improve mesothelioma outcomes
Disease control Recruiting nowThe purpose of this study is to find out whether intraperitoneal or intravenous chemotherapy given after cytoreductive surgery and HIPEC are effective treatments for people with malignant peritoneal mesothelioma. Outcomes will be compared by observing intraperitoneal versus intra…
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Electric field therapy plus radiation: new hope for pancreas cancer?
Disease control Recruiting nowThe purpose of this clinical trial is to determine whether using chemotherapy followed by stereotactic ablative body radiation therapy (SABR) and tumor treating fields (TTF) will slow tumor growth in people with locally advanced pancreas cancer. All participants will receive SABR…
Phase: NA • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New shot could help control bleeding in hemophilia a
Disease control Recruiting nowWP44714 is a Phase I/II, open-label, non-randomized, global, multicenter trial consisting of two parts: * Part 1 is a multiple-ascending dose (MAD) study in adult and adolescent male participants with severe or moderate hemophilia A with or without factor VIII (FVIII) inhibitors…
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug XKH004 shows promise in phase 3 trial for back pain from ankylosing spondylitis
Disease control CompletedThis is a multicenter, randomized, double-blind, placebo-controlled, and parallel grouping study. Study procedures: The screening period does not exceed 4 weeks, including 16 weeks for initial treatment, 28 weeks for maintenance treatment and 8 weeks for safety follow-up.
Phase: PHASE3 • Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New pill targets rare bile duct cancer mutation in late-stage trial
Disease control OngoingThis study used a randomized, controlled, double-blind, multicenter Phase III clinical design with overall survival (OS) as the primary endpoint. About 165 patients with advanced biliary carcinoma were enrolled and randomly assigned to the experimental group and the control group…
Phase: PHASE3 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New vaccine combo aims to outsmart neuroblastoma relapse
Disease control Recruiting nowThe purpose of this study is to test which treatment schedule of β-glucan with bivalent vaccine is more effective for participants with high-risk neuroblastoma that is in complete remission.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New school program aims to cut asthma attacks in disadvantaged kids
Disease control Recruiting nowOur UH3 clinical trial, "Reducing Asthma Attacks in Disadvantaged School Children with Asthma," seeks broad-scale implementation of our effective school-based approach to improve asthma disparities for children, ages 5-12 years, in low-income communities. The investigators will c…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New vaccine aims to tackle two viruses behind hand, foot, and mouth disease
⭐️ VACCINE ⭐️ CompletedThe Phase I clinical trial is divided into two parts. The first part uses an open-label design, while the second part uses a randomized, double-blind, and controlled design. The goal of this clinical trial is to evaluate the tolerability and safety of a bivalent (EV71/CA16, Enter…
Phase: PHASE1, PHASE2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 28, 2026 00:00 UTC
-
Radioactive bullet targets Hard-to-Treat prostate cancer
Disease control OngoingResearchers are looking for a better way to treat people who have advanced metastatic castration-resistant prostate cancer (mCRPC). In participants with metastatic castration-resistant prostate cancer (mCRPC), the cancer of the prostate has spread to other parts of the body (meta…
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New Clot-Busting device could save lives in pulmonary embolism
Disease control OngoingEvaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.
Phase: NA • Sponsor: Inquis Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Weight-Loss drug tirzepatide aims to help people keep pounds off Long-Term
Disease control CompletedThe main purpose of this study is to evaluate the efficacy and safety of tirzepatide for the maintenance of body weight reduction.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a Two-Pronged attack shrink Hard-to-Treat cancers?
Disease control TerminatedIn this study, participants with different types of advanced solid tumors who failed standard treatments will be treated with XNW5004 in combination with KEYTRUDA® (pembrolizumab) .
Phase: PHASE1, PHASE2 • Sponsor: Evopoint Biosciences Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
HIV vaccine candidate VIR-1388 passes early safety check in 93 volunteers
⭐️ VACCINE ⭐️ CompletedThe purpose of this study is to evaluate the safety, reactogenicity, and immunogenicity of VIR 1388 in adults in good health without HIV.
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:09 UTC
-
New hope for breast cancer brain metastases? drug combo trial launches
Disease control Recruiting nowThis study evaluated the safety and efficacy of SPH4336 in combination with endocrine therapy in breast cancer Patients with brain metastases.
Phase: PHASE2 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Promising drug cocktail targets Hard-to-Treat liver cancer
Disease control CompletedTo evaluate the efficacy and safety of cadonilimab combined with regorafenib in patients with HCC who progressed on systemic therapy.
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can school staff stop child trafficking? kentucky trial aims to find out
Prevention Recruiting nowFocus: Intervention \& prevention of child commercial sexual exploitation or trafficking (CST) In Kentucky, familial SU/D increases risk of CST. Primary goal: Implement and evaluate effectiveness of multi-level bystander-informed program (CSTOP Now!) aimed at Kentucky public mid…
Phase: NA • Sponsor: Ann Coker • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Spine surgery samples could reveal silent heart disease
Diagnosis Recruiting nowPrimary objective: To identify older adults with transthyretin cardiac amyloidosis (ATTR-CA) early in the course of the illness, at a time when disease modifying therapies are most effective. The specific aims of this epidemiologic investigation include: 1. To identify subject…
Sponsor: Columbia University • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC
-
Can a radioactive peptide spot hidden amyloid in the heart?
Diagnosis Recruiting nowThis study will investigate 99mTc-p5+14, an amyloid-reactive synthetic peptide, p5+14, radiolabeled with technetium-99m, as a radiotracer for detecting paamyloid deposits in patients with AL or ATTR-associated systemic amyloidosis, notably with cardiac involvement.
Phase: PHASE1 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC